HIGHLIGHTS
- who: Renato Sablich from the Department University have published the article: Vedolizumab is superior to infliximab in biologic nau00efve patients with ulcerative colitis, in the Journal: Scientific Reports Scientific Reports
- what: The study was performed by using clinical, laboratory, and endoscopic data collected in the medical registry of the institution . Patients were selected during routine clinical follow-up using the data already stored in the medical records and were not exposed to any additional intervention for research purposes. Exclusion criteria were: the absence of written consent to the use of anonymous personal data for research . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.